Stifel lowered the firm’s price target on Iqvia to $255 from $269 and keeps a Buy rating on the shares. The firm believes trends in the business continue to be solid and the recent sell-off in the shares is unwarranted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IQV: